Sun.Sep 12, 2021

article thumbnail

Digital health approach improves neurosurgery care, says study

pharmaphorum

Deployment of digital health technologies during the pandemic improved patient satisfaction, expanded the delivery of care and augmented training of staff at a leading neurosurgery provider in the US, according to a new study. Faced with the disruption caused by the COVID-19 crisis, Cleveland Clinic centres implemented a number telehealth and audio-visual technologies to compensate for the difficulties in having face-to-face interactions with patients.

article thumbnail

Chinese Biopharma Strikes Deal with Western Company for COVID-19 Vaccine

BioSpace

Everest will pay Providence $50 million in cash upfront for access to its COVID-19 vaccine and other mRNA vaccine candidates targeting specific variants in earlier stages of development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New research proves diet can put Type 2 diabetes into remission

Scienmag

A change in diet is proving to be a key tool in the reversal of Type 2 diabetes. Credit: UBC Okanagan A change in diet is proving to be a key tool in the reversal of Type 2 diabetes. A team of researchers from the University of British Columbia and England’s Teesside University have published […].

article thumbnail

Study: 1/3 of Cancer Accelerated Approval Indications Remain Despite Lack of Confirmation

BioSpace

A recent study suggests that about one-third of cancer indications with Accelerated Approval pathways are still on product labels without follow-up studies confirming their benefits.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Association Between Physician Part-time Clinical Work and Patient Outcomes

JAMA Internal Medicine

This cross-sectional study examines the association between the number of days worked clinically per year by physicians and patient mortality.

75
article thumbnail

FDA Action Alert: Calliditas, Merck and BeiGene

BioSpace

September is turning out to be a busy month for the U.S. Food and Drug Administration. Here’s a look at this week’s schedule for PDUFA dates.

Drugs 90

More Trending

article thumbnail

AzurRx Carves Out Slice of IBD Market in $229 Million Buyout

BioSpace

AzurRx will change its name to First Wave BioPharma, Inc., and the company’s shares will trade on the Nasdaq under the ticker symbol “FWBI.

article thumbnail

Isotope mapping sheds rare light into migratory routes, natal origins of monarch butterflies

Scienmag

Pre-COVID-19 pandemic, University of Ottawa biology student Megan Reich enjoyed the road trip of a lifetime, crisscrossing the east coast of the United States in search of a specific thrill: Milkweed. Credit: Megan Reich, University of Ottawa Pre-COVID-19 pandemic, University of Ottawa biology student Megan Reich enjoyed the road trip of a lifetime, crisscrossing the […].

52
article thumbnail

Industry Veteran Rusty Williams Leads Startup to $50 Million Series A

BioSpace

South San Francisco-based Walking Fish started the week off strong by announcing its closing of a $50 million Series A financing round on Monday.

71
article thumbnail

First North Dakota Quarterly Drug Price Transparency Reports Due in October

FDA Law Blog

By Serra J. Schlanger — Earlier this year, North Dakota enacted a prescription drug price transparency reporting law, HB 1032 , that became effective on August 1, 2021. (See our summary here.) This new law requires prescription drug manufacturers to report the current wholesale acquisition cost (WAC) information for drugs sold in or into the state on a quarterly basis.

Drugs 52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Biopharma AI Collaborations Driving Innovative Change in Drug Development

BioSpace

AI can enable the analysis of massive databases, accelerate research and development, save costs and promote effective decision making.

article thumbnail

Children of cancer patients are too often excluded from the disease journey, research shows

Scienmag

Lugano, Switzerland, 13 September 2021 – The announcement of a cancer diagnosis abruptly and durably alters the course of daily life – not just for the person receiving it, but also for their family. New research (1) [to be] presented at the ESMO Congress 2021 suggests that adequate communication and support for children of cancer patients still represents a significant unmet need that parents require help to fulfil.

article thumbnail

Clinical Catch-Up: September 6-10

BioSpace

It was a very busy week for clinical trial announcements, although there were only three that were COVID-19-related. Here’s a look.

article thumbnail

Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government

BioTech 365

Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government Saint-Herblain (France), September 13, 2021 – Valneva SE, a specialty vaccine company, today announced … Continue reading →

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

AbbVie, REGENXBIO Partner on Potential One-Time Treatment for Wet AMD

BioSpace

?The drug, called RGX-314, is a possible one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal diseases.

Drugs 84
article thumbnail

Relief Therapeutics Provides Update on Regulatory Interactions in the United Kingdom and European Union Relating to Lead Drug Candidate, RLF-100 (Aviptadil)

BioTech 365

RELIEF THERAPEUTICS Holding AG / Key word(s): Study 13-Sep-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.

Drugs 40
article thumbnail

A Recurring COVID-19 Origin Theory and a Vaccine for Kids by Halloween?

BioSpace

Dr. Scott Gottlieb estimated that a vaccine for the 5-11-year-old age group could be available by Halloween – in a best-case scenario.

article thumbnail

Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire

BioTech 365

Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire PARIS–(BUSINESS WIRE)–#ai–Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that Gold Coast … Continue reading →

Trials 52
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Five Life Sciences Companies Ramping up the Fall Flood of IPOs

BioSpace

Experts are predicting a record-breaking rush of IPOs this fall as companies flood to the Nasdaq.

article thumbnail

Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial

BioTech 365

Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies WALTHAM, Mass.

Trials 52
article thumbnail

AVITA's Personalized Vaccine Kit Elicits Robust Immune Memory Response

BioSpace

?The Phase II study showed enhanced immune memory response to the virus in 96% of vaccinated subjects, all of whom were exposed to an environment dominated by the delta variant.

article thumbnail

BeiGene to Present Latest Findings in Robust Lung Cancer Portfolio at ESMO Congress 2021

BioTech 365

BeiGene to Present Latest Findings in Robust Lung Cancer Portfolio at ESMO Congress 2021 BeiGene to Present Latest Findings in Robust Lung Cancer Portfolio at ESMO Congress 2021 CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi—BeiGene, Ltd.

52
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

BeiGene's Immuno-oncology Portfolio Running Strong in Lung Cancer

BioSpace

BeiGene plans to describe the power of its lung cancer portfolio at the European Society for Medical Oncology Congress 2021. The conference will run from September 16-21.

70
article thumbnail

EMD Serono to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021

BioTech 365

EMD Serono to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021 EMD Serono to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021 27 abstracts showcase the Company’s innovation in the areas of immuno-oncology, oncogenic … Continue reading →

52
article thumbnail

Fred Frank, 'Founding Father' of Biotech, Dead at 89

BioSpace

Frederick Frank, an innovator of biotech investment who played a key role in Roche’s acquisition of Genentech and the merger that formed Bristol-Myers Squibb, has died.

70
article thumbnail

Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021

BioTech 365

Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021 Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021 27 abstracts showcase the Company’s innovation in the areas of immuno-oncology, oncogenic pathways, and … Continue reading →

52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Survey Says Immunotherapy May be Effective for Early-Stage Cancer Treatment

BioSpace

In a recent multinational survey, healthcare providers expressed the belief that immunotherapy will improve outcomes for patients with earlier-stage cancers.

52
article thumbnail

Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress

BioTech 365

Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) … Continue reading →

52
article thumbnail

Inappropriate Sexual Behavior Allegations Confirmed Against Aubrey de Grey

BioSpace

SENS Research Foundation released findings that confirmed the charges of inappropriate behavior raised by two former female employees against Aubrey de Grey.

article thumbnail

BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress

BioTech 365

BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress … Continue reading →

Trials 40
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.